Tumor necrosis factor-beta +252A polymorphism is associated with systemic lupus erythematosus in Taiwan

Journal of the Formosan Medical Association

Volumn 104, Issue 8, 2005, Pages 563-570

  Lu, Ling Ying ^a   Cheng, He Hsiung ^a   Sung, Ping Kuang ^a   Tai, Ming Hong ^a   Yeh, Jeng Jung ^b   Chen, Angela ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Interleukin 10; Interleukin 4; Systemic lupus erythematosus; Transforming growth factor beta1; Tumor necrosis factor alpha; Tumor necrosis factor beta

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 10; INTERLEUKIN 4; LYMPHOTOXIN; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENZYME IMMUNOASSAY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; GENE LINKAGE DISEQUILIBRIUM; GENETICS; IMMUNOLOGY;

ADULT; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOTOXIN-ALPHA; MALE; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27744491305     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Horwitz DA, Stohl W, Gray JD: T lymphocytes, natural killer cells, cytokines, and immune regulation. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2002:157-86.
2. Liossis SC, Tsokos GC: B cell abnormalities in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2002:205-18.
3. Arnett FC, Reveille JD: Genetics of systemic lupus erythematosus. Rheum Dis Clin Am 1992;18:865-92.
4. Tsao BP: The genetics of human lupus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2002:97-120.
5. Schur PH: Genetics of systemic lupus erythematosus. Lupus 1995; 4:425-37.
6. Lu LY, Ding WZ, Fici D, et al: Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997;40:1138-45.
7. Wilson AG, Gordon C, di Giovine FS, et al: A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994;24:191-5.
8. Sullivan KE, Wooten C, Schmeckpeper BJ, et al: A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997;40:2207-11.
9. Fong KY, Howe HS, Tin SK, et al: Polymorphism of the regulatory region of tumor necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore 1996; 25:90-3.
10. Messer G, Spengler U, Jung MC, et al: Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991;173:209-19.
11. Bettinotti MP, Hartung K, Deicher H, et al: Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNF-β-MHC haplotypes. Immunogenetics 1993;37:449-54.
12. Goldstein R, Sengar DP: Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum 1993;36:1121-7.
13. Kim TG, Kim HY, Lee SH, et al: Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. Hum Immunol 1996;46: 10-7.
14. Lee SH, Park SH, Min JK, et al: Decreased tumor necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans. Lupus 1997; 6:603-9.
15. Llorente L, Richaud-Patin Y, Couderc J, et al: Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1429-35.
16. Richaud-Patin Y, Alcocer-Varela J, Llorente L: High levels of Th2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995;47:267-72.
17. Noguchi E, Shivasaki M, Arinami T, et al: Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998;28:449-53.
18. Houssiau FA, Lefebvre C, van den Berghe M, et al: Serum interleukin-10 titres in systemic lupus erythematosus reflect disease activity. Lupus 1995;4:393-5.
19. Lazarus M, Hajeer AH, Turner D, et al: Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997;24:2314-7.
20. Mok CC, Lanchbury JS, Chan DW, et al: Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1090-5.
21. Rood MJ, Keijsers V, van der Linden MW, et al: Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin-10 promoter haplotypes. Ann Rheum Dis 1999;58: 85-9.
22. Gray JD, Hirokawa M, Horwitz DA: The role of transforming growth factor-β in the generation of suppression: an interaction between CD8+ T and NK cells. J Exp Med 1994;180:1937-42.
23. Yamagowa S, Gray JD, Hashimoto S, et al: A role of TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 2001;166:7282-9.
24. Ohtsuka K, Gray JD, Stimmler MM, et al: Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J Immunol 1998;160:2539-45.
25. Ohtsuka K, Gray JD, Quismorio FP, et al: Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-β1. Lupus 1999;8:95-102.
26. Ohtsuka K, Gray JD, Stimmler MM, et al: The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity and severity. Lupus 1999;8:90-4.
27. Schotte H, Willeke P, Rust S, et al: The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 2003;12:86-92.
28. Lan JL, Su P, Lin FZ, et al: The study of HLA class I, II, III antigens in Chinese patients with systemic lupus erythematosus in Taiwan [abstract]. Asian Pacific Congress of Allergy and Clinical Immunology 1995:S16-6.
29. Tan EM, Cohen AS, Fries JF, et al: 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
30. Kimura A, Sasazuki T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Oxford: Oxford University Press; 1992:397-419.
31. Lu LY, Cheng HH, Sung PK, et al: Single-nucleotide polymorphisms of transforming growth factor-β1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect 2004;37:145-52.
32. Wu MC, Huang CM, Tsai JJP, et al: Polymorphisms of the interleukin-4 gene in Chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003;12:21-5.
33. Kanemitsu S, Takabayashi A, Sasaki Y, et al: Association of interleukin-4 and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus. Arthritis Rheum 1999;42: 1297-303.
34. Yamada Y, Okuizumi H, Miyauchi A, et al: Association of transforming growth factor-β1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 2000;43:452-60.
35. Cambien F, Richard S, Troesch A, et al: Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. Hypertension 1996;28:881-8.
36. Walley AJ, Cookson WO: Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996;33:689-92.
37. Syrris P, Carter ND, Metcalfe JC, et al: Transforming growth factor-β1 gene polymorphisms and coronary artery disease. Clin Sci 1998;95:659-67.
38. Green AJ, Barcello LF, Rimmler JB, et al: Multiple sclerosis genetic group. Sequence variation in the transforming growth factor-β1 gene and multiple sclerosis susceptibility. J Neuroimmunol 2001;116:116-24.
39. Froncek MJ, Horwitz DA: Cytokines in the pathogenesis of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2002:187-204.
40. Jacob CO, Fronek Z, Lewis GD, et al: Heritable major histocompatibility complex II-associated differences in production of tumor necrosis factor-α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:1233-7.
41. Wacholder S, Rothman N, Caporaso N: Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 2002;11:513-20.
42. Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-3.
43. Wilson AG, de Vries N, Pociot F, et al: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177:557-60.